Diabetic retinopathy in the Czech National Diabetes Programme 2012–2022

Czech version

Authors: T. Pelikánová
Authors‘ workplace: Centrum diabetologie IKEM Praha, přednostka prof. MUDr. Terezie Pelikánová, DrSc.
Published in: Vnitř Lék 2013; 59(3): 214-217
Category: Reviews

Overview

Diabetic retinopathy (DR) develops in patients with both type 1 and type 2 diabetes and is the major cause of vision loss and blindness in people of working age. In the Czech Republic, the number of patients with diabetic retinopathy is still increasing as well as the number of diabetic patients. It is known, that the comprehensive preventive and therapeutic procedures reduce the risk of visual loss by more than 90%. These procedures include intervention of modifiable risk factors (especially hypertension and hyperglycaemia), active screening of DR and specialized ophthalmologic treatment. The Czech National Diabetes Programme 2012–2022, which is built on similar initiatives as in 1984 and 2000, has been completed in late 2012. Its main goal is to improve the health outcomes for people diabetes in the Czech Republic. The programme includes specific procedures aimed at improvement of organization and treatment providing to patients with diabetic retinopathy.

Key words:
diabetic retinopathy –⁠ organization of health care

Sources

1. Ústav zdravotnických informací a statistiky. Péče o nemocné s cukrovkou 2011, Praha 2012 (www.uzis.cz).

2. Kalvodová B, Sosna T, Řehák J et al za výbory České diabetologické společnosti a České oftalmologické společnosti. Doporučené postupy pro diagnostiku a léčbu diabetické retinopatie. DMEV 2012; 15 : 30–34 (www.diab.cz).

3. Česká diabetologická společnost ČLS JEP, Diabetická asociace ČR, Společnost všeobecných lékařů ČLS JEP. Národní diabetologický program 2012–2022. DMEV 2012; 15 : 179–197 (www.diab.cz).

4. Škrha J za výbor České diabetologické společnosti ČLS JEP. Epidemiologická studie o diabetes mellitus v České republice. Porovnání výsledků z roku 2002 a 2006. DMEV 2010; 13 : 55–62.